This finding was close to that reported (65%) among American patients with type 1 or type 2 diabetes [15] and much lower than another study (87.5%) focusing on patients with type 1 diabetes users of insulin pump therapy [20]. The gene discussed is INS; the disease is type 2 diabetes mellitus.